Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection

ClinicalTrials.gov ID: NCT00013520

Public ClinicalTrials.gov record NCT00013520. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 6:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase III, Randomized, Double-Blind Comparison of Three Protease Inhibitor-Sparing Regimens for the Initial Treatment of HIV Infection

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare the effectiveness, safety, and tolerability of 3 anti-HIV combination treatments that do not use protease inhibitors (PIs). The current rule for starting treatment of HIV infection is to combine members from different classes of anti-HIV drugs, such as 2 nucleoside reverse transcriptase inhibitors (NRTIs) and either a PI or a nonnucleoside reverse transcriptase inhibitor (NNRTI). However, these combinations can be complicated and difficult to take, can cause a number of side effects, and may become ineffective. Combinations that are simpler, better tolerated, and more effective are needed. Because PIs can cause long-term side effects and because HIV can become resistant to many of them at the same time, anti-HIV combination treatments that do not use PIs are being tested.

Study identification

NCT ID
NCT00013520
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
1,125 participants

Conditions and interventions

Eligibility (public fields only)

Age range
16 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Jun 2005 (Actual)
Last update posted
May 21, 2012

Ends 2005

United States locations

U.S. sites
59
U.S. states
22
U.S. cities
37
Facility City State ZIP Site status
Alabama Therapeutics CRS Birmingham Alabama 35294 —
USC CRS Los Angeles California 900331079 —
UCLA CARE Center CRS Los Angeles California 90095 —
Stanford CRS Palo Alto California — —
UC Davis Medical Center Sacramento California 95814 —
Univ. of California Davis Med. Ctr., ACTU Sacramento California — —
Ucsd, Avrc Crs San Diego California 92103 —
Ucsf Aids Crs San Francisco California 94110 —
Santa Clara Valley Med. Ctr. San Jose California — —
San Mateo County AIDS Program San Mateo California 943055107 —
Willow Clinic A0507 CRS San Mateo California — —
Harbor-UCLA Med. Ctr. CRS Torrance California 90502 —
University of Colorado Hospital CRS Aurora Colorado 80262 —
Georgetown University CRS (GU CRS) Washington D.C. District of Columbia 20007 —
Univ. of Miami AIDS CRS Miami Florida 331361013 —
The Ponce de Leon Ctr. CRS Atlanta Georgia 30308 —
Univ. of Hawaii at Manoa, Leahi Hosp. Honolulu Hawaii 96816 —
Northwestern University CRS Chicago Illinois 60611 —
Rush Univ. Med. Ctr. ACTG CRS Chicago Illinois 60612 —
Cook County Hosp. CORE Ctr. Chicago Illinois — —
Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis Indiana 462025250 —
Indiana Univ. School of Medicine, Wishard Memorial Indianapolis Indiana 46202 —
Methodist Hosp. of Indiana Indianapolis Indiana 46202 —
Univ. of Iowa Healthcare, Div. of Infectious Diseases Iowa City Iowa 52242 —
Johns Hopkins Adult AIDS CRS Baltimore Maryland 21287 —
Massachusetts General Hospital ACTG CRS Boston Massachusetts 02114 —
Bmc Actg Crs Boston Massachusetts 02118 —
Beth Israel Deaconess Med. Ctr., ACTG CRS Boston Massachusetts 02215 —
Brigham and Women's Hosp. ACTG CRS Boston Massachusetts — —
SSTAR, Family Healthcare Ctr. Fall River Massachusetts — —
University of Minnesota, ACTU Minneapolis Minnesota 55455 —
St. Louis ConnectCare, Infectious Diseases Clinic St Louis Missouri — —
Washington U CRS St Louis Missouri — —
Univ. of Nebraska Med. Ctr., Durham Outpatient Ctr. Omaha Nebraska 681985130 —
SUNY - Buffalo, Erie County Medical Ctr. Buffalo New York 14215 —
Beth Israel Med. Ctr., ACTU New York New York 10003 —
Weill Med. College of Cornell Univ., The Cornell CTU New York New York 10011 —
NY Univ. HIV/AIDS CRS New York New York 10016 —
Cornell CRS New York New York 10021 —
Columbia Univ., HIV Prevention and Treatment Medical Ctr. New York New York 10032 —
HIV Prevention & Treatment CRS New York New York — —
Univ. of Rochester ACTG CRS Rochester New York 14642 —
AIDS Care CRS Rochester New York — —
McCree McCuller Wellness Ctr. at the Connection, Infectious Disease Unit Rochester New York — —
Unc Aids Crs Chapel Hill North Carolina 275997215 —
Duke Univ. Med. Ctr. Adult CRS Durham North Carolina 27710 —
Regional Center for Infectious Disease, Wendover Medical Center CRS Greensboro North Carolina 27401 —
Univ. of Cincinnati CRS Cincinnati Ohio 452670405 —
Case CRS Cleveland Ohio 44106 —
MetroHealth CRS Cleveland Ohio 441091998 —
The Ohio State Univ. AIDS CRS Columbus Ohio 432101228 —
Philadelphia Veterans Admin. Med. Ctr. A6205 CRS Philadelphia Pennsylvania 19104 —
Univ. of Pennsylvania Health System, Presbyterian Med. Ctr. Philadelphia Pennsylvania 19104 —
Hosp. of the Univ. of Pennsylvania CRS Philadelphia Pennsylvania — —
Pitt CRS Pittsburgh Pennsylvania 15213 —
The Miriam Hosp. ACTG CRS Providence Rhode Island 02906 —
Rhode Island Hosp. Providence Rhode Island — —
Vanderbilt Therapeutics CRS Nashville Tennessee 37203 —
University of Washington AIDS CRS Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00013520, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 21, 2012 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00013520 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →